Biopharma News : Biopharma and Pharma news from all around the world :
- MAIA Biotechnology Reports Full Year 2022 Financial Results and Provides Corporate Update
- ClinAI Chooses The Sales Ops Group to Accelerate Sales Transformation and Drive Value Proposition Alignment
- Karuna Therapeutics Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
- Devonian Health Group Announces voting results of the Annual General and Special Meeting and welcome new board members
- Clinical Data Interchange Standards Consortium (CDISC) and the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital (MRCT Center) Collaborate to Offer Plain Language Clinical Research Definitions as a New Standard
- Resilience Approved for $410M Financing from the Department of Defense, in Partnership with the Development Finance Corporation, to Establish Resilient Biomanufacturing Capacity
- A New Day at Danco: Delaware Courts Clear Way for Era of Responsible Leadership and Governance at U.S. License Holder for Mifepristone
- Miravo Healthcare Ranks on The Globe and Mail’s Fourth-Annual Women Lead Here Benchmark of Executive Gender Diversity
- Tivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast
- bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
- Quantum-Si to Participate in B. Riley Securities’ Life Sciences Tools Conference – Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference
- Global Bioengineered Protein Drugs Market to Reach $521.3 Billion by 2027: Increasing Prevalence of Chronic Diseases Drives Growth – ResearchAndMarkets.com
- BenevolentAI Announces Publication of Convening Notice for AGM
- Incyte Provides Regulatory Update on Ruxolitinib Extended-Release Tablets
- Swisslog Healthcare Promotes Eric Waski to Senior Vice President – Technology Center
- Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Letter of Intent for a Business Combination
- Aptar Named a CDP Supplier Engagement Leader for the Third Consecutive Year
- Rite Aid to Release Fourth Quarter Results on April 20
- Harrow Announces Fourth Quarter and Year-End 2022 Financial Results
- Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
- Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates
- Pragma Bio Secures $10M From The Venture Collective, Merck Global Health Innovation Fund, Viking Global, and CJ Investments To Expand Its Proprietary Technology Platform To Discover Novel Medicines
- Cala TAPS Therapy for Essential Tremor Patients Improves Outcomes in a New Randomized Controlled Trial
- NeuroRPM Inc. Announces FDA Clearance for NeuroRPM, the AI-Powered Remote Monitoring App for Parkinson’s Disease on Apple Watch
- Lunaphore Raises CHF 40M in the First Close of Series D Funding led by EGS Beteiligungen AG
- 3DHISTECH and Epredia Open Pathology Innovation Incubator to Accelerate Advancements in Cancer Diagnostics
- Mihir Sanghvi Joins IPS Southern California Team as Director of Engineering
- nference Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
- Bliss Bio Health to Sponsor CSweetener Mentorship Breakfast at ViVE 2023
- Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer
Biotech – Biopharma News!
- MorphoSys AG: Repurchase of portion of outstanding convertible bonds due 2025 (ISIN DE000A3H2XW6)
- Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
- Evotec receives US$ 6.6 m grant for drug discovery in tuberculosis
- Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business
- Evolva publishes agenda for 2023 Annual General Meeting
- Eckert & Ziegler with Unchanged Dividend Proposal
- Original-Research: Haemato AG (von First Berlin Equity Research GmbH)
- MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6)
- Biotest AG: Biotest core business profitable at Euro 60.7 million
- Zur Rose Group: Revenue and earnings targets for 2022 achieved; significant step towards profitability
- Cosmo reports record 2022 financial results exceeding guidance, increased dividend by 10%, confirms 2023 guidance
- Sernova: Abstract on First Cohort of its Phase 1/2 Study Involving Islet Transplantation into Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 83rd Scientific Sessions
- Dermapharm Holding SE: 2022 dividend
- Douglas GmbH: DOUGLAS accelerates growth with strict customer focus and targeted omni-channel set-up
- Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
- PolyPeptide publishes invitation to the annual General Meeting 2023
- Cosmo Pharmaceuticals announces that Cosmo Intelligent Medical Devices – IMD Ltd, fully owned subsidiary of Cosmo Pharmaceuticals, and Medtronic to expand cooperation on GI Genius™
- Evotec SE to announce preliminary financial results for fiscal year 2022 on 28 March 2023
- aap receives US-American clearance (FDA) for polyaxial LOQTEQ® VA Elbow system; launch planned for Q4 2023
- Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23
- New clinical study demonstrates Medacta’s MySpine accuracy in screw replacement during spine revision surgery
- Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
- AEVIS VICTORIA SA – Consolidated EBITDA 2022 up by more than 60% to between CHF 125 and 130 million (2021: CHF 78.4m); net profit 2022 will exceed CHF 60 million (2021: CHF 4.6m)
- Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
- Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
- Medacta Group SA: 2022 Full Year Results
- Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical
- Newron to present at the 31st European Congress of Psychiatry
- Abivax adjusts its 2023 Financial Communication Calendar
- PAION IS HOSTING A SPONSORED ANGIOTENSIN II SYMPOSIUM AT ISICEM IN BRUSSELS
- Ordinary and Extraordinary General Meeting of April 12, 2023
- IntelGenx Revises Fourth Quarter and Full Year 2022 Financial Results Reporting and Conference Call Date to March 29, 2023
- Alimera Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 31, 2023, and Provide Corporate Update
- Theriva Biologics to Reschedule Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results
- Iovance Biotherapeutics Completes Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma
- Oral semaglutide 25 mg and 50 mg demonstrate superior reductions in HbA1c and body weight versus 14 mg in people with type 2 diabetes in the PIONEER PLUS phase 3 trial
- Assure Holdings Regains Compliance with NASDAQ Continued Listing Requirements
- Renowned Public Health Advisor Jim O’Neill Joins Board of Directors of ADvantage Therapeutics
- BioSig Announces New Advisory Board Member Lorraine Spurge
- Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
- Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
- Ventyx Biosciences to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
- Ryvu Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
- CancerVax CEO Ryan Davies Speaks with University of Utah Chemistry Professor about the Future of Therapeutic Research
- Ultimovacs ASA: Annual Report 2022
- Philips convenes the Annual General Meeting of Shareholders 2023
- OKYO Pharma Announces PDMR Dealing
- COMPLETION OF DIRECTED ISSUE OF 11,577,957 NEW B SHARES AND 250,000 EXISTING TREASURY B SHARES
- Vitalhub Corp. Reports Fourth Quarter and Full Year 2022 Results
- Unity Care Receives $100,000 California State Coastal Conservancy Grant
- Amedisys Supports New Research that Demonstrates the Value of Hospice Care Through Better Outcomes and Medicare Savings
- Bioasis Provides Update on Business Operations
- Celyad Oncology reports full year 2022 financial results and recent business highlights
- Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
- Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary
- Inventiva announces the schedule of publication and presentation of its 2022 Full-Year Financial Results
- Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema
- Orion and Bayer expand clinical development program for darolutamide in prostate cancer
- Orion and Bayer expand clinical development program for darolutamide in prostate cancer
- National Survey Finds Majority of Healthcare Workers Have Considered Leaving Their Roles or the Industry Altogether in the Past Year as Burnout Intensifies
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News